2017 ACR指南：糖皮质激素诱发的骨质疏松症的预防和治疗

2017-06-06 美国风湿病学会 Arthritis Rheumatol. 2017 Jun 6.

2017年6月，美国风湿病学会(ACR)发布了糖皮质激素诱发的骨质疏松症的预防和治疗指南，本文为临床医生治疗糖皮质激素诱发的骨质疏松症患者提供决策指导，建议内容涉及骨折风险评估和重新评估，治疗以及随访等。

中文标题：

英文标题：

2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

发布机构：

美国风湿病学会

发布日期：

2017-06-06

简要介绍：

2017年6月，美国风湿病学会(ACR)发布了糖皮质激素诱发的骨质疏松症的预防和治疗指南，本文为临床医生治疗糖皮质激素诱发的骨质疏松症患者提供决策指导，建议内容涉及骨折风险评估和重新评估，治疗以及随访等。

拓展指南：与骨科相关指南：

有关骨科更多指南

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=dc9641c001a50599, title=2017 ACR指南：糖皮质激素诱发的骨质疏松症的预防和治疗, enTitle=2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis., guiderFrom=Arthritis Rheumatol. 2017 Jun 6., authorId=null, author=, summary=2017年6月，美国风湿病学会(ACR)发布了糖皮质激素诱发的骨质疏松症的预防和治疗指南，本文为临床医生治疗糖皮质激素诱发的骨质疏松症患者提供决策指导，建议内容涉及骨折风险评估和重新评估，治疗以及随访等。, cover=, journalId=null, articlesId=null, associationId=528, associationName=美国风湿病学会, associationIntro=The American College of Rheumatology's mission is advancing rheumatology. The organization is for physicians, health professionals, and scientists that meets the mission through programs of education, research, advocacy and practice support. The ACR provides professional education for its members through several venues. The Annual Scientific Meeting, held each fall, is the premier scientific meeting devoted to the rheumatic diseases. This meeting draws thousands of rheumatologists and arthritis health professionals from around the world. A winter rheumatology symposium, spring clinical meetings, and other topical conferences round out the ACR's educational offerings., copyright=0, guiderPublishedTime=Tue Jun 06 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=2017年6月，美国风湿病学会(ACR)发布了糖皮质激素诱发的骨质疏松症的预防和治疗指南，本文为临床医生治疗糖皮质激素诱发的骨质疏松症患者提供决策指导，建议内容涉及骨折风险评估和重新评估，治疗以及随访等。 拓展指南：与骨科相关指南： <ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=c8b3f1c001a25ede" title="从最新指南看临床实践《中国骨科大手术静脉血栓栓塞症预防指南》解读" target=_blank>从最新指南看临床实践《中国骨科大手术静脉血栓栓塞症预防指南》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=06a691c0012988ca" title="2016 中国医师协会骨科医师分会循证临床诊疗指南：成人急性枢椎骨折循证临床诊疗指南" target=_blank>2016 中国医师协会骨科医师分会循证临床诊疗指南：成人急性枢椎骨折循证临床诊疗指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=295d11c00118939b" title="第九届骨科年会最新《骨质疏松性骨折干预循证临床诊疗指南》解读" target=_blank>第九届骨科年会最新《骨质疏松性骨折干预循证临床诊疗指南》解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c0e5c1c0011e13a2" title="中国骨科大手术静脉血栓栓塞症预防指南 2015" target=_blank>中国骨科大手术静脉血栓栓塞症预防指南 2015</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=ffe821c001115514" title="2014 骨科生物力学研究的测量方法学专家共识" target=_blank>2014 骨科生物力学研究的测量方法学专家共识</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E9%AA%A8%E7%A7%91" target=_blank>有关骨科更多指南</a></ul>, tagList=[TagDto(tagId=541, tagName=糖皮质激素), TagDto(tagId=2404, tagName=骨质), TagDto(tagId=48625, tagName=疏松症), TagDto(tagId=2246, tagName=预防), TagDto(tagId=65, tagName=治疗)], categoryList=[CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=19, categoryName=老年医学, tenant=100), CategoryDto(categoryId=21067, categoryName=梅斯医学-骨质疏松网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5587, appHits=393, showAppHits=0, pcHits=4266, showPcHits=1518, likes=139, shares=18, comments=4, approvalStatus=1, publishedTime=Thu Jun 08 10:11:12 CST 2017, publishedTimeString=2017-06-06, pcVisible=1, appVisible=1, editorId=5295982, editor=yanqin, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=yanqin, createdTime=Thu Jun 08 10:11:12 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:24:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 ACR指南：糖皮质激素诱发的骨质疏松症的预防和治疗)])

2017 ACR指南：糖皮质激素诱发的骨质疏松症的预防和治疗

下载请点击：

评论区 (3)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=892642, encodeId=b3068926422d, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MnthNYiaYT4SNKeEmLuaew25SGJGqorNxwqGloYHGW3w3nejQ4MFuxMSzRUSet8SrfxeIrY1eXiawvkOExTUQ5mA/132, createdBy=746a5235316, createdName=弯豆钰, createdTime=Sat Oct 17 12:26:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=247838, encodeId=028124e838aa, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcohE5MKT1FYlH69x7qib45icLgBDMANxIiauEA62nuQI1eE8Ez2rO3yqOkRLH6ha6Lw0x1IBRm0N7g/0, createdBy=e1ff2033933, createdName=187****0626, createdTime=Tue Sep 26 09:43:30 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208168, encodeId=b50320816839, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65eb1955460, createdName=1e123c29m78(暂无匿称), createdTime=Thu Jun 08 14:04:26 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
2020-10-17 弯豆钰

赞

76 0
[GetPortalCommentsPageByObjectIdResponse(id=892642, encodeId=b3068926422d, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MnthNYiaYT4SNKeEmLuaew25SGJGqorNxwqGloYHGW3w3nejQ4MFuxMSzRUSet8SrfxeIrY1eXiawvkOExTUQ5mA/132, createdBy=746a5235316, createdName=弯豆钰, createdTime=Sat Oct 17 12:26:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=247838, encodeId=028124e838aa, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcohE5MKT1FYlH69x7qib45icLgBDMANxIiauEA62nuQI1eE8Ez2rO3yqOkRLH6ha6Lw0x1IBRm0N7g/0, createdBy=e1ff2033933, createdName=187****0626, createdTime=Tue Sep 26 09:43:30 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208168, encodeId=b50320816839, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65eb1955460, createdName=1e123c29m78(暂无匿称), createdTime=Thu Jun 08 14:04:26 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
2017-09-26 187****0626

不错

76 0
[GetPortalCommentsPageByObjectIdResponse(id=892642, encodeId=b3068926422d, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/MnthNYiaYT4SNKeEmLuaew25SGJGqorNxwqGloYHGW3w3nejQ4MFuxMSzRUSet8SrfxeIrY1eXiawvkOExTUQ5mA/132, createdBy=746a5235316, createdName=弯豆钰, createdTime=Sat Oct 17 12:26:01 CST 2020, time=2020-10-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=247838, encodeId=028124e838aa, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDcohE5MKT1FYlH69x7qib45icLgBDMANxIiauEA62nuQI1eE8Ez2rO3yqOkRLH6ha6Lw0x1IBRm0N7g/0, createdBy=e1ff2033933, createdName=187****0626, createdTime=Tue Sep 26 09:43:30 CST 2017, time=2017-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=208168, encodeId=b50320816839, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65eb1955460, createdName=1e123c29m78(暂无匿称), createdTime=Thu Jun 08 14:04:26 CST 2017, time=2017-06-08, status=1, ipAttribution=)]
2017-06-08 1e123c29m78(暂无匿称)

赞

74 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

骨科指南

2017 ACR指南：糖皮质激素诱发的骨质疏松症的预防和治疗

相关指南

科室

工具

服务